Otc - Active Ingredient
Sodium hyaluronate
Curithys
FDA Label NDC 72945-0002
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by J World for the product Curithys (NDC 72945-0002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
Niacinamide
Salicylic Acid
Sh-Oligopepide-1
Sh-Polypepide-1
TetraPeptide-44
Centella Asiatica Extract
Tranexamic acid
Camellia Japonica Flower Extract
Otc - Purpose
Micro-pyramid stimulates the skin and gives moisture and nutrition to sensitive skin.
Otc - Keep Out Of Reach Of Children
keep out of reach of the children
Indications & Usage
Remove the protective film from the patch.
Attach it vertically to the desired site.
Re-press on thea ttached patch every few minutes..
Remove the patch after attaching for more than 1 hour.
Warnings
Use it for your own use only.
For external use only.
Discontinue use if adverse reaction occurs.
Contact a physician if symptoms persist.
Store at room temperature
.Do not reuse it as a disposable product.
Please use it immediately after opening.
Dosage & Administration
for topical use only
Package Label.Principal Display Panel
Label (Label)
* Please review the disclaimer below.
